Apexigen Inc.

NASDAQ: APGN · Real-Time Price · USD
0.39
0.04 (9.86%)
At close: Aug 22, 2023, 9:59 PM

Apexigen Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
14.8M 23.44M
Short-Term Investments
2M 12.92M
Long-Term Investments
n/a 58.09M
Other Long-Term Assets
1.41M -57.76M
Receivables
n/a n/a
Inventory
n/a n/a
Other Current Assets
2.62M 1.68M
Total Current Assets
21.19M 38.04M
Property-Plant & Equipment
250K 728K
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
1.66M 1.05M
Total Assets
22.86M 39.1M
Account Payables
5.34M 4.49M
Deferred Revenue
5.66M 3.61M
Short-Term Debt
106K 369K
Other Current Liabilities
5.36M 8.49M
Total Current Liabilities
16.47M 16.95M
Long-Term Debt
n/a 141K
Other Long-Term Liabilities
11K 158.71M
Total Long-Term Liabilities
11K 158.85M
Total Liabilities
16.48M 175.8M
Total Debt
106K 510K
Common Stock
2K 31K
Retained Earnings
-176.79M -144.72M
Comprehensive Income
n/a -4K
Shareholders Equity
6.38M -136.71M
Total Investments
2M 12.92M